AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3
slide-4
slide-5

Megatas 25 Tablet ER

Prescription Icon
Prescription Required

Marketer

Intas Pharmaceuticals Ltd

Salt Composition

Mirabegron (25mg)

Overview Megatas 25 Tablet ER

Overactive bladder symptoms, such as frequent urination, urgency, and incontinence, are managed with Megatas 25 ER tablets. This medication relaxes bladder muscles, improving urine storage capacity. Always follow your doctor's prescribed dosage and duration; it may be taken with or without food. Swallow the tablet whole—do not crush or chew. Discontinue use only after consulting your physician, as this could exacerbate symptoms. Complete the prescribed course for optimal results. Potential side effects include constipation, headache, hypertension, rhinitis, urinary tract infection, tachycardia, and arthralgia. Report persistent or bothersome side effects promptly. Before starting treatment, disclose all other medications and any existing health conditions, including pregnancy or breastfeeding. Individuals with liver or kidney impairment require careful monitoring and regular check-ups as directed by their doctor.

Primary Ingredients of Megatas 25 Tablet ER

There is no text provided to rewrite.

Uses of Megatas 25 Tablet ER

Managing symptoms associated with overactive bladder

Major Benefits of Megatas 25 Tablet ER:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Megatas 25 Tablet ER can be consumed with or without food, however, consistent daily timing is recommended.

Common Side effects of Megatas 25 Tablet ER:

  • Constipation
  • Headache
  • High blood pressure
  • Nasal inflammation
  • Urinary tract infection
  • Fast heart rate
  • Joint pain

How to use Megatas 25 Tablet ER:

Follow your doctor's instructions precisely regarding the dosage and treatment length for Megatas 25 Tablet ER. Ingest the tablet whole; avoid chewing, crushing, or breaking it. While it can be taken with or without food, consistency is key—take it at the same time each day.

How Megatas 25 Tablet ER works:

Bladder relaxation is achieved by Megatas 25 ER tablets, a beta-3 adrenergic agonist. This medication acts on bladder receptors, reducing muscle contractions and thus alleviating urinary urgency, frequency, and incontinence.

SAFETY ADVICE

AlcoholAlcoholCAUTION

Use caution when combining Megatas 25 ER tablets and alcohol. Seek medical advice before doing so.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Megatas 25 Tablet may pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Megatas 25mg tablets are likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingSAFE

Driving ability is typically unaffected by Megatas 25 Extended-Release Tablets.

KidneyKidneyCAUTION

Exercise caution when administering Megatas 25 Extended-Release Tablets to individuals with significant renal impairment. Dosage modification of Megatas 25 Extended-Release Tablets might be necessary. Physician consultation is recommended.

LiverLiverCAUTION

Exercise caution when administering Megatas 25 Tablet ER to individuals with hepatic impairment; dosage modification may be necessary. Physician consultation is advised. Megatas 25 Tablet ER is contraindicated in patients exhibiting severe liver dysfunction.

What if you forget to take Megatas 25 Tablet ER :

Should you forget a Megatas 25 Tablet ER dose, take it immediately. However, if your next dose is nearly due, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Megatas 25 Tablet ER

LabelValue
Chemical Classification Anilide-based Compound
Developing Habits No.
Type of Therapy Urology
Action Class Beta-3 agonist for bladder control

FAQs on Megatas 25 Tablet ER

Optimal Megatas 25 Tablet ER effects may become apparent after eight weeks or more of treatment. Dosage adjustments may be considered after four to eight weeks, depending on individual response.
Continue taking Megatas 25 Tablet ER even if your symptoms improve. This medication treats overactive bladder symptoms—urgency, frequent urination, and incontinence—but doesn't cure the condition. Stopping treatment could cause your symptoms to return.
Megatas 25 Tablet ER shouldn't interfere with your sleep. Consult your doctor about any sleep issues.
Megatas 25 Tablet ER should not be given to children under 18 because its safety and efficacy haven't been established in this age group.
No, consistent daily use, as prescribed, is crucial. This medication manages your condition, not curing it. Intermittent use prevents your bladder from fully adapting, hindering effectiveness and leading to symptom recurrence.
Megatas 25 Tablet ER may cause kidney, ureter, bladder, or urethra infection, though this is not universal. Renal stones and bladder pain have been rarely reported. Patients with impaired kidney function should use caution and report any kidney-related adverse effects to their physician.
Megatas 25 Tablet ER may raise blood pressure; monitor your blood pressure regularly if you have hypertension. This medication is contraindicated in patients with severe, uncontrolled hypertension.
Seek immediate medical help, regardless of how you feel. A Megatas 25 Tablet ER overdose can elevate your heart rate and blood pressure, potentially causing severe headache, palpitations, chest pain, and fatigue.
Megatas 25 Tablet ER
260
MRP 301
13% off